Current Management of Purpura Fulminans: A Multicenter Study
Authors:
- 1 May 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Burn Care & Rehabilitation
- Vol. 24 (3) , 119-126
Abstract
Seven burn centers performed a 10-yr retrospective chart review of patients diagnosed with purpura fulminans. Patient demographics, etiology, presentation, medical and surgical treatment, and outcome were reviewed. A total of 70 patients were identified. Mean patient age was 13 yr. Neisseria meningitidis was the most common etiologic agent in infants and adolescents whereas Streptococcus commonly afflicted the adult population. Acute management consisted of antibiotic administration, volume resuscitation, ventilatory and inotropic support, with occasional use of corticosteroids (38%) and protein C replacement (9%). Full-thickness skin and soft-tissue necrosis was extensive, requiring skin grafting and amputations in 90% of the patients. One fourth of the patients required amputations of all extremities. Fasciotomies when performed early appeared to limit the level of amputation in 6 of 14 patients. Therefore, fasciotomies during the initial management of these patients may reduce the depth of soft-tissue involvement and the extent of amputations.Keywords
This publication has 26 references indexed in Scilit:
- Dysfunction of Endothelial Protein C Activation in Severe Meningococcal SepsisNew England Journal of Medicine, 2001
- Purpura FulminansJournal of Burn Care & Rehabilitation, 1998
- Management strategy in purpura fulminans with multiple organ failure in childrenBurns, 1996
- Surgical intervention for the complications of meningococcal-induced purpura fulminansThe Pediatric Infectious Disease Journal, 1994
- Epidemic Meningococcemia and Purpura Fulminans with Induced Protein C DeficiencyClinical Infectious Diseases, 1993
- Purpura FulminansAnnals of Plastic Surgery, 1988
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Purpura FulminansClinical Orthopaedics and Related Research, 1985
- The Effects of High-Dose Corticosteroids in Patients with Septic ShockNew England Journal of Medicine, 1984